| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4291763 | Journal of the American College of Surgeons | 2015 | 11 Pages |
Abstract
When compared between the institutes where LDLT or DDLT were the first treatment choices for unresectable HCC, recurrence rates were comparable. Living donor liver trasplantation is a viable treatment option for unresectable HCC, providing recurrence rates similar to those achieved with DDLT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Mizuki MD, PhD, Ken MD, PhD, FACS, Marcelo E. MD, Myron E. MD, Sander S. MD, FACS, Tomoharu MD, PhD, FACS, Norifumi MD, PhD, Toru MD, PhD, FACS, Hideaki MD, PhD, Yoshihiko MD, PhD, FACS,